DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,129 filers reported holding DANAHER CORPORATION in Q2 2017. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,849,138 | +45.9% | 27,413 | +45.8% | 1.34% | -6.1% |
| Q1 2024 | $4,695,485 | -25.7% | 18,803 | -31.2% | 1.43% | +4.8% |
| Q4 2023 | $6,321,134 | -9.2% | 27,324 | -2.5% | 1.36% | -18.3% |
| Q3 2023 | $6,959,113 | +53.2% | 28,035 | +48.1% | 1.67% | +58.7% |
| Q2 2023 | $4,542,251 | -9.7% | 18,926 | -5.1% | 1.05% | -12.6% |
| Q1 2023 | $5,028,215 | -34.0% | 19,950 | -30.5% | 1.20% | -36.2% |
| Q4 2022 | $7,619,667 | -2.8% | 28,708 | -5.1% | 1.88% | -4.9% |
| Q3 2022 | $7,839,000 | +3.5% | 30,253 | +1.5% | 1.98% | +10.9% |
| Q2 2022 | $7,573,000 | -15.2% | 29,796 | -2.0% | 1.79% | +7.9% |
| Q1 2022 | $8,933,000 | -23.9% | 30,389 | -14.6% | 1.66% | -16.1% |
| Q4 2021 | $11,745,000 | +2.1% | 35,600 | -5.5% | 1.97% | -3.7% |
| Q3 2021 | $11,498,000 | +20.1% | 37,667 | +5.7% | 2.05% | +15.1% |
| Q2 2021 | $9,576,000 | +20.5% | 35,619 | +1.1% | 1.78% | +9.5% |
| Q1 2021 | $7,944,000 | +3.1% | 35,222 | +1.6% | 1.62% | +3.1% |
| Q4 2020 | $7,702,000 | +5.6% | 34,661 | +2.3% | 1.58% | -3.8% |
| Q3 2020 | $7,291,000 | +28.9% | 33,882 | +5.9% | 1.64% | +11.5% |
| Q2 2020 | $5,657,000 | +28.4% | 32,007 | +0.5% | 1.47% | +3.9% |
| Q1 2020 | $4,406,000 | -7.4% | 31,837 | +2.7% | 1.41% | +12.7% |
| Q4 2019 | $4,757,000 | +9.4% | 30,996 | +2.9% | 1.26% | -4.2% |
| Q3 2019 | $4,349,000 | +6.2% | 30,112 | +5.0% | 1.31% | +12.3% |
| Q2 2019 | $4,097,000 | +824.8% | 28,669 | +653.7% | 1.17% | +770.1% |
| Q2 2018 | $443,000 | -83.7% | 3,804 | -86.4% | 0.13% | -86.4% |
| Q4 2017 | $2,726,000 | +1.4% | 27,971 | -6.5% | 0.98% | -3.3% |
| Q3 2017 | $2,688,000 | +5.3% | 29,926 | -1.1% | 1.02% | +5.8% |
| Q2 2017 | $2,553,000 | +4.2% | 30,247 | +5.6% | 0.96% | +1.8% |
| Q1 2017 | $2,451,000 | -26.9% | 28,654 | -33.5% | 0.95% | -35.2% |
| Q4 2016 | $3,355,000 | -9.1% | 43,095 | -8.4% | 1.46% | -6.4% |
| Q3 2016 | $3,689,000 | -31.1% | 47,056 | -11.2% | 1.56% | -38.2% |
| Q2 2016 | $5,351,000 | +18.6% | 52,983 | +11.4% | 2.52% | +11.7% |
| Q1 2016 | $4,510,000 | +25.6% | 47,544 | +11.2% | 2.26% | +1.2% |
| Q4 2015 | $3,592,000 | +34.1% | 42,755 | +36.0% | 2.23% | +33.6% |
| Q3 2015 | $2,678,000 | +197.2% | 31,436 | +201.1% | 1.67% | +201.8% |
| Q2 2015 | $901,000 | +32.5% | 10,441 | +30.4% | 0.55% | +4.3% |
| Q1 2015 | $680,000 | +81.3% | 8,007 | +83.0% | 0.53% | +117.2% |
| Q4 2014 | $375,000 | +111.9% | 4,375 | +89.3% | 0.24% | +39.4% |
| Q3 2014 | $177,000 | +30.1% | 2,311 | +34.0% | 0.18% | +44.6% |
| Q2 2014 | $136,000 | +86.3% | 1,725 | +77.3% | 0.12% | +101.7% |
| Q1 2014 | $73,000 | – | 973 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |